Delpharm Huningue

Delpharm is a prominent player in the Contract Development and Manufacturing Organization (CDMO) sector, recognized for its extensive capabilities in the development and production of pharmaceuticals. With over 30 years of experience, the company is positioned among the top five global CDMO providers. Delpharm specializes in various forms of medications, including solid oral forms, semi-solids, non-sterile liquids, and sterile products, and operates 19 production and development sites across Europe and North America. Recently, Delpharm has initiated a significant modernization project at its Boucherville facility in Canada, leveraging a $60 million investment from the Quebec government. This modernization is aimed at enhancing the production processes for sterile injectable medications, which are essential for Canadian patients. Furthermore, the company has invested in a new sterile filling line at its Saint-Rémy site to support the increased demand for aseptic vials, reflecting Delpharm's commitment to growth and operational excellence. Delpharm emphasizes a human-centric approach in its workplace strategy, focusing on team collaboration, employee well-being, and continuous improvement. This culture is reinforced by leadership that encourages responsibility and initiative among staff members, fostering an environment conducive to performance and teamwork. The company also highlights its adherence to corporate social responsibility (CSR) practices, as evidenced by its ongoing efforts to uphold high-quality standards, implement sustainable practices, and nurture its workforce. In addition to these advancements, Delpharm has expanded its service offerings through the acquisition of a pharmaceutical manufacturing site in the Netherlands and is actively involved in the development and production of pre-filled syringes, catering to diverse client needs. Overall, Delpharm's strategic investments and commitment to quality and innovation position it as a reliable partner in the pharmaceutical industry, ready to meet evolving market demands.